28 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 35514314 | Starvation mediates pancreatic cancer cell sensitivity to ferroptosis via ERK1/2, JNK and changes in the cell mesenchymal state. | 2022 Jun | 1 |
2 | 33258389 | GIT1 overexpression promotes epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma. | 2021 Dec | 2 |
3 | 33595872 | Inhibition of BRAF and ERK1/2 has synergistic effects on thyroid cancer growth in vitro and in vivo. | 2021 Mar | 1 |
4 | 33807122 | Antitumoral Activity of the MEK Inhibitor Trametinib (TMT212) Alone and in Combination with the CDK4/6 Inhibitor Ribociclib (LEE011) in Neuroendocrine Tumor Cells In Vitro. | 2021 Mar 23 | 1 |
5 | 33816264 | TMPRSS4 Promotes Cell Proliferation and Inhibits Apoptosis in Pancreatic Ductal Adenocarcinoma by Activating ERK1/2 Signaling Pathway. | 2021 | 1 |
6 | 33816301 | Targeting the MDSCs of Tumors In Situ With Inhibitors of the MAPK Signaling Pathway to Promote Tumor Regression. | 2021 | 1 |
7 | 34062009 | miR-506-loaded gelatin nanospheres target PENK and inactivate the ERK/Fos signaling pathway to suppress triple-negative breast cancer aggressiveness. | 2021 Aug | 1 |
8 | 34610960 | DCLK1-Short Splice Variant Promotes Esophageal Squamous Cell Carcinoma Progression via the MAPK/ERK/MMP2 Pathway. | 2021 Dec | 1 |
9 | 34697988 | EloA promotes HEL polyploidization upon PMA stimulation through enhanced ERK1/2 activity. | 2021 Oct 26 | 2 |
10 | 34770830 | Neuroprotective Effects of B-Type Cinnamon Procyanidin Oligomers on MPP+-Induced Apoptosis in a Cell Culture Model of Parkinson's Disease. | 2021 Oct 24 | 1 |
11 | 32576853 | Genome-wide DNA methylation analysis of KRAS mutant cell lines. | 2020 Jun 23 | 1 |
12 | 32705806 | Andrographolide attenuates epithelial-mesenchymal transition induced by TGF-β1 in alveolar epithelial cells. | 2020 Sep | 1 |
13 | 30361508 | Increased invasive phenotype of CSF-1R expression in glioma cells via the ERK1/2 signaling pathway. | 2019 May | 1 |
14 | 30362626 | lncRNA DRHC inhibits proliferation and invasion in hepatocellular carcinoma via c-Myb-regulated MEK/ERK signaling. | 2019 Mar | 1 |
15 | 30426301 | Involvement of ERK1/2 activation in the gene expression of senescence-associated secretory factors in human hepatic stellate cells. | 2019 May | 1 |
16 | 30754024 | Incorporation of cerium oxide in hollow mesoporous bioglass scaffolds for enhanced bone regeneration by activating the ERK signaling pathway. | 2019 Mar 28 | 1 |
17 | 30899402 | JQ1 effectively inhibits vasculogenic mimicry of pancreatic ductal adenocarcinoma cells via the ERK1/2-MMP-2/9 signaling pathway both in vitro and in vivo. | 2019 | 2 |
18 | 31031847 | The Down-Regulation of SUZ12 Accelerates the Migration and Invasion of Liver Cancer Cells via Activating ERK1/2 Pathway. | 2019 | 1 |
19 | 29733883 | Distinct apoptotic blocks mediate resistance to panHER inhibitors in HER2+ breast cancer cells. | 2018 Aug | 1 |
20 | 29888601 | Javamide-II Found in Coffee Is Better than Caffeine at Suppressing TNF-α Production in PMA/PHA-Treated Lymphocytic Jurkat Cells. | 2018 Jul 5 | 1 |
21 | 30213106 | Newcastle Disease Virus V Protein Promotes Viral Replication in HeLa Cells through the Activation of MEK/ERK Signaling. | 2018 Sep 12 | 1 |
22 | 30568786 | Quantitation of ERK1/2 inhibitor cellular target occupancies with a reversible slow off-rate probe. | 2018 Dec 7 | 2 |
23 | 28821612 | Syndecan-2 cytoplasmic domain up-regulates matrix metalloproteinase-7 expression via the protein kinase Cγ-mediated FAK/ERK signaling pathway in colon cancer. | 2017 Sep 29 | 1 |
24 | 26832798 | Dissecting Therapeutic Resistance to ERK Inhibition. | 2016 Apr | 3 |
25 | 25142146 | Antitumor activity of the ERK inhibitor SCH772984 [corrected] against BRAF mutant, NRAS mutant and wild-type melanoma. | 2014 Aug 20 | 2 |
26 | 25195011 | A unique inhibitor binding site in ERK1/2 is associated with slow binding kinetics. | 2014 Oct | 3 |
27 | 23614898 | Discovery of a novel ERK inhibitor with activity in models of acquired resistance to BRAF and MEK inhibitors. | 2013 Jul | 2 |
28 | 23847348 | ERK pathway inhibitors: how low should we go? | 2013 Jul | 1 |